EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal

Lori A Devlin, Zhuopei Hu, Stephanie L Merhar, Songthip T Ounpraseuth, Alan E Simon, Jeannette Y Lee, Abhik Das, Margaret M Crawford, Rachel G Greenberg, P Brian Smith, Rosemary D Higgins, Michele C Walsh und 23 weitere

JAMA Pediatrics · 01.06.2024 · 178 (6) · 525

DOI: 10.1001/jamapediatrics.2024.0544 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Pediatrics, erschienen am 01.06.2024. Verfasst von Lori A Devlin und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky. Hauptthemen laut MEDLINE: Neonatal Abstinence Syndrome, Analgesics, Opioid. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The function-based eat, sleep, console (ESC) care approach substantially reduces the proportion of infants who receive pharmacologic treatment for neonatal opioid withdrawal syndrome (NOWS). This reduction has led to concerns for increased postnatal opioid exposure in infants who receive pharmacologic treatment. However, the effect of the ESC care approach on hospital outcomes for infants pharmacologically treated for NOWS is currently unknown.

Objective

To evaluate differences in opioid exposure and total length of hospital stay (LOS) for pharmacologically treated infants managed with the ESC care approach vs usual care with the Finnegan tool. Design, Setting, and Participants This post hoc subgroup analysis involved infants pharmacologically treated in ESC-NOW, a stepped-wedge cluster randomized clinical trial conducted at 26 US hospitals. Hospitals maintained pretrial practices for pharmacologic treatment, including opioid type, scheduled opioid dosing, and use of adjuvant medications. Infants were born at 36 weeks’ gestation or later, had evidence of antenatal opioid exposure, and received opioid treatment for NOWS between September 2020 and March 2022. Data were analyzed from November 2022 to January 2024. Exposure Opioid treatment for NOWS and the ESC care approach. Main Outcomes and Measures For each outcome (total opioid exposure, peak opioid dose, time from birth to initiation of first opioid dose, length of opioid treatment, and LOS), we used generalized linear mixed models to adjust for the stepped-wedge design and maternal and infant characteristics.

Results

In the ESC-NOW trial, 463 of 1305 infants were pharmacologically treated (143/603 [23.7%] in the ESC care approach group and 320/702 [45.6%] in the usual care group). Mean total opioid exposure was lower in the ESC care approach group with an absolute difference of 4.1 morphine milligram equivalents per kilogram (MME/kg) (95% CI, 1.3-7.0) when compared with usual care (4.8 MME/kg vs 8.9 MME/kg, respectively; P = .001). Mean time from birth to initiation of pharmacologic treatment was 22.4 hours (95% CI, 7.1-37.7) longer with the ESC care approach vs usual care (75.4 vs 53.0 hours, respectively; P = .002). No significant difference in mean peak opioid dose was observed between groups (ESC care approach, 0.147 MME/kg, vs usual care, 0.126 MME/kg). The mean length of treatment was 6.3 days shorter (95% CI, 3.0-9.6) in the ESC care approach group vs usual care group (11.8 vs 18.1 days, respectively; P < .001), and mean LOS was 6.2 days shorter (95% CI, 3.0-9.4) with the ESC care approach than with usual care (16.7 vs 22.9 days, respectively; P < .001). Conclusion and Relevance When compared with usual care, the ESC care approach was associated with less opioid exposure and shorter LOS for infants pharmacologically treated for NOWS. The ESC care approach was not associated with a higher peak opioid dose, although pharmacologic treatment was typically initiated later. Trial Registration ClinicalTrials.gov Identifier: NCT04057820

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal Abstinence SyndromeAnalgesics, OpioidHumansFemaleInfant, NewbornMaleLength of StaySleep

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky.
  • Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock.
  • University of Cincinnati College of Medicine and Perinatal Institute, Division of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • IDeA States Pediatric Clinical Trials Network (ISPCTN), Environmental Influences on Child Health Outcomes (ECHO) Program, National Institutes of Health, Rockville, Maryland.
  • National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland.
  • Social, Statistical and Environmental Sciences Unit, RTI International, Research Triangle Park, North Carolina.

Förderung

  • NIH HHS

Zitieren

APA

Devlin, L. A., Hu, Z., Merhar, S. L., Ounpraseuth, S. T., Simon, A. E., Lee, J. Y., Das, A., Crawford, M. M., Greenberg, R. G., Smith, P. B., Higgins, R. D., Walsh, M. C., Rice, W., Paul, D. A., Maxwell, J. R., Fung, C. M., Wright, T., Ross, J., McAllister, J. M., …, & Eunice Kennedy Shriver NICHD Neonatal Research Network and NIH Environmental Influences on Child Health Outcomes (ECHO) Program Institutional Development Award… (2024). Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal. JAMA Pediatrics, 178(6), 525. https://doi.org/10.1001/jamapediatrics.2024.0544

Vancouver

Devlin LA, Hu Z, Merhar SL, Ounpraseuth ST, Simon AE, Lee JY, et al. Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal. JAMA Pediatrics. 2024;178(6):525. doi:10.1001/jamapediatrics.2024.0544

BibTeX
@article{Devlin2024,
  author = {Devlin, Lori A and Hu, Zhuopei and Merhar, Stephanie L and Ounpraseuth, Songthip T and Simon, Alan E and Lee, Jeannette Y and Das, Abhik and Crawford, Margaret M and Greenberg, Rachel G and Smith, P Brian and Higgins, Rosemary D and Walsh, Michele C and Rice, Ward and Paul, David A and Maxwell, Jessie R and Fung, Camille M and Wright, Tanner and Ross, Julie and McAllister, Jennifer M and Crowley, Moira and Shaikh, Sophie K and Christ, Lori and Brown, Jaime and Riccio, Julie and Wong Ramsey, Kara and Braswell, Erica F and Tucker, Lauren and McAlmon, Karen and Dummula, Krishna and Weiner, Julie and White, Jessica R and Newman, Sarah and Snowden, Jessica N and Young, Leslie W and Eunice Kennedy Shriver NICHD Neonatal Research Network and NIH Environmental Influences on Child Health Outcomes (ECHO) Program Institutional Development Award…, Eunice Kennedy Shriver NICHD Neonatal Research Network and NIH Environmental Influences on Child Health Outcomes (ECHO) Program Institutional Development Award…},
  title = {Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal},
  journal = {JAMA Pediatrics},
  year = {2024},
  volume = {178},
  number = {6},
  pages = {525},
  doi = {10.1001/jamapediatrics.2024.0544}
}
Kostenlos starten →